Publikationen in Zusammenarbeit mit Forschern von Centro de Investigación Médica Aplicada (15)

2019

  1. Parkinson’s disease with mild cognitive impairment: severe cortical thinning antedates dementia

    Brain Imaging and Behavior, Vol. 13, Núm. 1, pp. 180-188

2018

  1. Gamma-aminobutyric acid (GABA) receptors genes polymorphisms and risk for restless legs syndrome

    Pharmacogenomics Journal, Vol. 18, Núm. 4, pp. 565-577

2017

  1. Association between the rs1229984 polymorphism in the alcohol dehydrogenase 1B gene and risk for restless legs syndrome

    Sleep, Vol. 40, Núm. 12

  2. Thr105Ile (rs11558538) polymorphism in the histamine-1-methyl-transferase (HNMT) gene and risk for restless legs syndrome

    Journal of Neural Transmission, Vol. 124, Núm. 3, pp. 285-291

2016

  1. Significance of visual hallucinations and cerebral hypometabolism in the risk of dementia in Parkinson's disease patients with mild cognitive impairment

    Human Brain Mapping, Vol. 37, Núm. 3, pp. 968-977

  2. Stimulation sites in the subthalamic nucleus and clinical improvement in Parkinson's disease: A new approach for active contact localization

    Journal of Neurosurgery, Vol. 125, Núm. 5, pp. 1068-1079

2015

  1. Association between Vitamin D receptor rs731236 (Taq1) polymorphism and risk for restless legs syndrome in the Spanish caucasian population

    Medicine (United States), Vol. 94, Núm. 47, pp. e2125

  2. Heme Oxygenase-1 and 2 Common Genetic Variants and Risk for Restless Legs Syndrome

    Medicine (United States), Vol. 94, Núm. 34, pp. e1448

2014

  1. Grey matter hypometabolism and atrophy in Parkinson's disease with cognitive impairment: A two-step process

    Brain, Vol. 137, Núm. 8, pp. 2356-2367

  2. High beta activity in the subthalamic nucleus and freezing of gait in Parkinson's disease

    Neurobiology of Disease, Vol. 64, pp. 60-65

2013

  1. Spinal hydatidosis relapse related to albendazole withdrawal after 20-year treatment

    Spine Journal, Vol. 13, Núm. 6, pp. 715-716

2012

  1. The impact of silent vascular brain burden in cognitive impairment in Parkinson's disease

    European Journal of Neurology, Vol. 19, Núm. 8, pp. 1100-1107

2011

  1. Involvement of the subthalamic nucleus in impulse control disorders associated with Parkinson's disease

    Brain, Vol. 134, Núm. 1, pp. 36-49

2010

  1. Progression of dopaminergic depletion in a model of MPTP-induced Parkinsonism in non-human primates. An 18F-DOPA and 11C-DTBZ PET study

    Neurobiology of Disease, Vol. 38, Núm. 3, pp. 456-463

2009

  1. Homocysteine and cognitive impairment in Parkinson's disease: A biochemical, neuroimaging, and genetic study

    Movement Disorders, Vol. 24, Núm. 10, pp. 1437-1444